Benserazide hydrochloride
CAS No. | 14919-77-8 | Cat. No. | BCP14068 |
Name | Benserazide hydrochloride | ||
Synonyms | Benserazide HCl; 2'-(2,3,4-Trihydroxybenzyl)-DL-serinohydrazide monohydrochloride; | ||
Formula | C10H15N3O5.HCl | M. Wt | 293.71 |
Description | Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor. It inhibits this decarboxylation, and since it itself cannot cross the blood-brain barrier, this allows dopamine to build up solely in the brain instead. Adverse effects caused by peripheral dopamine, such as nausea and arrhythmia, are minimized. However, benserazide cannot reduce the centrally-mediated side effects of levodopa, particularly dyskinesia. | ||
Pathways | Others Pathway | ||
Targets | Others |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.